Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NSPH

(NSPH) (NSPH) Stock Price, News & Analysis

(NSPH) logo

About (NSPH) Stock (NASDAQ:NSPH)

Advanced Chart

Key Stats

Today's Range
$1.69
$1.69
50-Day Range
N/A
52-Week Range
$0.48
$3.64
Volume
N/A
Average Volume
886,293 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.

Receive NSPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter.

NSPH Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

NSPH Stock Analysis - Frequently Asked Questions

(NSPH) (NASDAQ:NSPH) announced its quarterly earnings results on Monday, May, 16th. The medical research company reported ($0.55) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.04. The company's revenue for the quarter was up 43.5% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Meta Platforms (META), Advanced Micro Devices (AMD), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL) and Molecular Templates (MTEM).

Company Calendar

Last Earnings
5/16/2016
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NSPH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:NSPH) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners